Together with the evidences that relate oxidative stress and inflammation to the pathophysiology of diabetes, studies performed in a variety of cell and animal based experimental systems also suggest that NFκB activation is a key event early in the pathobiology of this disease and its complications [27, 58, 59]. Here, NFKB1 is linked to diabetes mellitus.